Adsorption of viral particles from the blood plasma of patients with viral hepatitis on nanodiamonds

被引:7
|
作者
Baron, A. V. [1 ,2 ]
Osipov, N. V. [3 ]
Yashchenko, S. V. [3 ]
Kokotukha, Yu. A. [3 ]
Baron, I. J. [4 ]
Puzyr, A. P. [1 ]
Olkhovskiy, I. A. [5 ,6 ]
Bondar, V. S. [1 ]
机构
[1] Russian Acad Sci, Siberian Branch, Inst Biophys, Krasnoyarsk 660036, Russia
[2] Siberian Fed Univ, Svobodnyi Pr 79, Krasnoyarsk 660041, Russia
[3] Krasnoyarsk Reg Ctr Prevent & Control AIDS, Ul Karla Marksa 47, Krasnoyarsk 660049, Russia
[4] Voino Yasenetskii State Med Univ, Minist Hlth Russian Federat, Ul Partizana Zheleznyaka 1, Krasnoyarsk 660022, Russia
[5] Minist Hlth Russian Federat, Krasnoyarsk Branch, Hematol Res Ctr, Krasnoyarsk, Russia
[6] Russian Acad Sci, Siberian Branch, Krasnoyarsk Res Ctr, Krasnoyarsk 630036, Russia
关键词
D O I
10.1134/S1607672916040037
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Adsorption of viral particles from the blood plasma of patients with viral hepatitis B and C on modified nanodiamonds (MNDs) was shown in the in vitro experiments. PCR method showed the treatment of plasma with MNDs leads to a decrease in the viral load by 2-3 orders of magnitude or more in both cases studied. These results make it possible to predict the applicability of MNDs for the development of new technologies of hemodialysis and plasmapheresis for binding and removal of viral particles from the blood of infected patients.
引用
收藏
页码:244 / 246
页数:3
相关论文
共 50 条
  • [1] Adsorption of viral particles from the blood plasma of patients with viral hepatitis on nanodiamonds
    A. V. Baron
    N. V. Osipov
    S. V. Yashchenko
    Yu. A. Kokotukha
    I. J. Baron
    A. P. Puzyr
    I. A. Olkhovskiy
    V. S. Bondar
    Doklady Biochemistry and Biophysics, 2016, 469 : 244 - 246
  • [2] Viral hepatitis and its risk from blood and plasma transfusions
    Buchanan, GR
    JOURNAL OF PEDIATRICS, 2005, 146 (05): : 687 - 687
  • [3] VIRAL HEPATITIS AND ITS RISK FROM BLOOD AND PLASMA TRANSFUSIONS
    DAVISON, WC
    JOURNAL OF PEDIATRICS, 1955, 46 (06): : 717 - 723
  • [4] Autotaxin and lysophosphatidic acid in the blood in patients of viral hepatitis
    Watanabe, N.
    Nakamura, K.
    Ohkawa, R.
    Tomiya, T.
    Yanase, M.
    Tejima, K.
    Nishikawa, T.
    Omata, M.
    Fujiwara, K.
    Yatomi, Y.
    Ikeda, H.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S171 - S171
  • [5] DESCRIPTION OF A VIRAL AGENT FOUND IN BLOOD OBTAINED FROM PATIENTS WITH INFECTIOUS HEPATITIS
    HARTWELL, WV
    EIDENBOCK, MP
    MURPHY, BL
    AUERNHEIMER, AH
    APPLIED MICROBIOLOGY, 1970, 19 (03) : 521 - +
  • [6] Current risks of viral hepatitis from blood transfusions
    Gresens, CJ
    Holland, PV
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1998, 13 (04) : 443 - 449
  • [7] VIRAL AGENTS FROM PATIENTS WITH INFECTIVE HEPATITIS
    COLE, RA
    AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE, 1965, 43 : 497 - &
  • [8] A Clinical Study of Plasma Fibronectin in Patients with Severe Viral Hepatitis
    刘建平
    向居正
    李奇芬
    Journal of Medical Colleges of PLA, 1987, (02) : 123 - 128
  • [9] ACTIVITY OF ADENOSINE DEAMINASE IN BLOOD SERUM OF VIRAL HEPATITIS PATIENTS
    KRAWCZYN.J
    RACZYNSK.J
    JONAS, S
    WENCEL, J
    ILOWIECK.K
    CLINICA CHIMICA ACTA, 1965, 11 (03) : 227 - &
  • [10] Blood Levels of Glutamine and Nitrotyrosine in Patients with Chronic Viral Hepatitis
    Murad, Hussam
    Tayeb, Haythum
    Mosli, Mahmoud
    Rafeeq, Misbahuddin
    Basheikh, Mohammed
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 8753 - 8762